JAKARTA (TheInsiderStories) – The Hermina Hospital manager, PT Medikaloka Hermina Tbk (IDX: HEAL) plans to build four new hospitals and also looking an opportunity to acquire another firm in 2021, said the management today. For this year’ business expansion, the issuer prepared a capital expenditure (capex) around Rp900 billion (US$63.83 million).
Currently, the operator has completed the Hermina Periuk Tangerang and opern the new hospital in November. Now, the provider is still building Hermina Cibitung in Bekasi, West Java. The company plans to open the hospital in the third quarter of 2021.
Director of Hemina, Aristo Setiawidjaja, reported his his office has pocketed fresh funds Rp20 billion from the private placement in this month. The funds came from its new investor, Luminous Investment Holdings Pte. Ltd., from Singapore. He explained the proceeds will be used for working capital needs.
One of the health provider’ goals are to acquire another hospital and buy back shares up to Rp100 billion. The buy back shares program held since Nov. 16 to Feb. 15, 2021 with a maximum price Rp4,000 a share. Last year, the company offered around 297.30 million shares or 10 percent of issued and fully paid up capital.
Based on the exercise price, Hermina could reap around Rp1.19 trillion of fresh funding with a dilution 9.09 percent. Apart from the rights issue, the operator has issued Rupiah bonds with a principal amount of Rp600 billion in September 2020.
Most of the funds, said Setiawidjaja, will be use to increases the hospital capacity also purchasing land, general and medical equipment, and for working capital. In 2020, the management is estimating to book a revenues around Rp4.35 trillion, or rises 20 percent compared to previous year.
In the first nine month of 2020, Hermina‘ net profit grew 24.56 from Rp210.05 billion to Rp261.65 billion. The net income stood at Rp2.88 trillion or grew 7.25 percent from the same period in 2019 worth of Rp 2.68 trillion.
The revenues consisted of inpatient income was Rp1.84 trillion and outpatient treatment of Rp1.01 trillion. While, non-hospital income was Rp16.48 billion or higher than the previous Rp16.21 billion.
Written by Editorial Staff, Email: firstname.lastname@example.org